EMR
50
2
RF
53
-3
BBY
43
3
PYPL
41
2
D
40
-5
INTC
41
5
CCI
28
3
MMM
28
-2
BK
66
-3
FOXA
59
7
OI
28
3
NKE
28
-2
AES
43
5
BEN
33
-5
MRK
25
2
AIZ
47
-2
TEL
60
-6
GRMN
68
-2
IVZ
48
-4
GIS
26
-14
EMR
50
2
RF
53
-3
BBY
43
3
PYPL
41
2
D
40
-5
INTC
41
5
CCI
28
3
MMM
28
-2
BK
66
-3
FOXA
59
7
OI
28
3
NKE
28
-2
AES
43
5
BEN
33
-5
MRK
25
2
AIZ
47
-2
TEL
60
-6
GRMN
68
-2
IVZ
48
-4
GIS
26
-14
Financhill
Back

Monopar Therapeutics Stock Predictions

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Buy
65

MNPR
Monopar Therapeutics

Last Price:
15.69
Seasonality Move:
4.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Monopar Therapeutics Stock Forecast

  • Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 116.6% based on the past 4 years of stock performance.
  • Monopar Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Monopar Therapeutics Stock Undervalued?
    The current Monopar Therapeutics [MNPR] share price is $17.22. The Score for MNPR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Monopar Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 116.6% based on the past 4 years of stock performance.

Monopar Therapeutics Stock Rating

Buy
65
Monopar Therapeutics (MNPR) is a Buy

Is Monopar Therapeutics overpriced?

  • Monopar Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Monopar Therapeutics Stock Price History

Is MNPR stock going to rise?

  • The current trend is moderately bullish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monopartx.com

52-Week Data

52-Week High:
38.50
52-Week Low:
1.37

Prediction Charts

Market Cap:
60.62M
Price in USD:
17.22
Volume:
632.89K
Beta:
1.11

Technical Analysis

SMA50:
6.41
SMA100:
4.89
SMA200:
4.09
52-Wk Change:
575.29%

Stock Predictions

  • Is Monopar Therapeutics stock public?
    Yes, Monopar Therapeutics is a publicly traded company.
  • What is the Monopar Therapeutics stock quote today?
    The Monopar Therapeutics stock price is 17.22 USD today.
  • How to buy Monopar Therapeutics stock online?
    You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 5.19 5.26 5.30 5.16
Oct-18 5.84 5.50 5.84 5.46
Oct-21 5.44 5.25 5.66 5.08
Oct-22 5.50 5.25 5.50 5.15
Oct-23 5.10 4.63 5.30 4.50
Oct-24 5.12 32.66 38.50 4.87
Oct-25 22.39 16.93 26.85 16.87
Oct-28 14.67 17.83 21.95 14.60
Oct-29 18.83 16.34 20.00 16.09
Oct-30 15.58 14.67 16.14 14.24
Oct-31 14.85 14.59 15.24 12.55
Nov-1 14.39 14.63 14.85 14.03
Nov-4 14.34 17.22 18.20 13.94
Nov-5 16.31 15.75 16.64 15.51

Monopar Therapeutics Earnings

Monopar Therapeutics Earnings Report: Per Share Monopar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Monopar Therapeutics Forecast Revenue Growth

Monopar Therapeutics Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and a decrease next year of $0.21 per share.

* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.